Clinical Trials 858 Views Preliminary results from Medivir Phase 2a study Malin Otmani August 23, 2023 The 15th patient with advanced …
MedTech Business 740 Views Episurf’s first commercial case in the US scheduled Malin Otmani August 23, 2023 Episurf Medical has announced that …
Business article 380 Views Sahlgrenska Science Park rebrands its accelerator Malin Otmani August 23, 2023 The life science science park …
Clinical Trials 835 Views First healthy volunteers dosed in Herantis’ part 2 Phase 1a study Malin Otmani August 22, 2023 Herantis Pharma has announced that …
MedTech Business 794 Views Bico announces goodwill impairment and its CEO steps down Malin Otmani August 22, 2023 The Group has resolved on …
Biotech Business 326 Views Alligator Bioscience receives orphan designation for mitazalimab Malin Otmani August 21, 2023 The European Medicines Agency (EMA) …
Biotech Business 340 Views FDA grants priority review for full approval of Calliditas’ TARPEYO Malin Otmani August 18, 2023 Calliditas Therapeutics has announced that …
Pharma Business 315 Views AstraZeneca’s Forxiga approved in China Malin Otmani August 18, 2023 Forxiga has been approved in …
Agreement 495 Views Sprint Bioscience licenses program to Day One Biopharmaceuticals Malin Otmani August 16, 2023 Sprint Bioscience has licensed the …
MedTech Award 940 Views Paindrainer wins the Nordic Health App Award Malin Otmani August 16, 2023 The company’s 360° patient-centric app …
Clinical Trials 1034 Views Calliditas announces full results from the NefIgArd Phase 3 trial Malin Otmani August 15, 2023 Calliditas Therapeutics has announced publication …
Clinical Trials 1023 Views Annexin reports promising study results Malin Otmani August 15, 2023 Annexin Pharmaceuticals has announced that …
In a new job 489 Views She is the new CEO of Oncopeptides Malin Otmani August 14, 2023 Oncopeptides has announced that CEO …
Acquisition 632 Views Novo Nordisk to acquire Inversago Pharma Malin Otmani August 10, 2023 Novo Nordisk has agreed to …
Clinical Trials 1204 Views Ultimovacs completes enrollment in Phase II trial Malin Otmani August 10, 2023 Ultimovacs has announced the completion …
Pharma Business 450 Views The European Commission has granted marketing authorization for Ztalmy Malin Otmani August 10, 2023 The European Commission has granted …
